Elanco, a division of Eli Lilly and Company, has launched into the UK companion animal market with a pledge to listen to vets and provide a highly personalised level of support.
The company will initially offer recognised brands such as equine vaccines…
Elanco Companion Animal Health has launched a novel prescription flea treatment for dogs which, according to the company, combines a rapid kill rate with convenient monthly oral administration.
Elanco says Comfortis Chewable Tablets for Dogs start to kill…
Elanco has announced the results of a challenge study which the company says demonstrates the ability of Duvaxyn IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Richmond/1/07 (H3N8) two weeks after a two dose primary course1.
The study…
Elanco (maker of Comfortis) has released the results of a survey of 1006 dog owners which showed that nearly half are not aware that turning on their central heating can cause pupal fleas to hatch and go in search of a host to feed on.
50% of those questioned…
Elanco has launched a new poultry tonic designed to support birds during the most demanding periods of productivity: during growth and peak laying.
The launch follows Elanco's acquisition of Janssen Animal Health and its existing poultry poultry tonic…
Elanco Animal Health has highlighted the results of a new study1 which concludes that Duvaxyn IE-T Plus stimulates a highter protective antibody response than four other equine influenza vaccines commercially available in Ireland.
The trial compared the…
Elanco Companion Animal Health, maker of Comfortis chewable tablets for dogs, has launched a range of support materials to help educate pet owners on flea infestation and the healthcare issues associated with fleas and encourage enquiries about flea control…
Elanco Companion Animal Health, maker of Comfortis, has launched a new campaign to raise awareness of the perennial problem of fleas, and the importance of regular treatment.
The campaign revolves around some new research which shows that while nearly…
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company…
Elanco Companion Animal Health has launched of Dexdomitor 0.1 mg/ml, adding to its range of alpha-2 agonists and antagonists.
Produced and manufactured in partnership with Orion Corporation, Elanco says Dexdomitor 0.1 mg/ml contains all the properties…
Elanco Companion Animal Health has announced that Comfortis (spinosad) flavoured chewable flea control tablets have been licensed for cats.
In addition, the company has extended its range with the addition of two new sizes for toy dogs and smaller…
Elanco Animal Health has announced the launch of Kexxtone this month, a new treatment which it claims can reduce the incidence of ketosis in dairy cows by 74%* following a single treatment.1
Kexxtone is a targeted solution for any dairy cow or heifer…
Elanco Companion Animal Health has launched Recuvyra 50mg/ml transdermal solution for dogs, the first transdermal fentanyl solution to be licensed for the control of postoperative pain associated with major orthopaedic and soft tissue surgery.
Recuvyra…
Elanco Companion Animal Health has launched a dermatology e-newsletter called Under The Skin, designed to help veterinary professionals stay informed and up to date on a wide range of skin conditions.
Featuring a guest editor for each edition, experts…
Elanco Companion Animal Health has launched Trifexis, an oral tablet to provide dogs with three-in-one protection against fleas, intestinal nematodes and heartworm.
Trifexis contains two active ingredients: spinosad, which is active against fleas, and…
Elanco has announced the results of a survey it conducted amongst European dermatology diplomates which found that nearly 90% of them consider Comfortis (spinosad) is the first choice of flea control for cats and dogs.
The research was conducted at the…
Elanco Animal Health has announced that there have been extensions to the withdrawal periods for Dectomax (doramectin) 10 mg/ml Solution for Injection and Micotil (tilmicosin) 300 mg/ml Solution for Injection.
For Dectomax injectable, meat withdrawal…
Elanco Companion Animal Health has launched a new ordering process for Recuvyra, its transdermal fentanyl solution for the control of postoperative pain relief in dogs.
The new process will enable veterinary practices to purchase Recuvyra, which is a…
Elanco Animal Health has launched AviPro Salmonella Duo, a new live vaccine which provides simultaneous protection against S Enteritidis and S Typhimurium in poultry.
Jessica Cross, Elanco's poultry veterinary consultant said: "AviPro Salmonella Duo…
Elanco Animal Health has launched Vulketan, a POM-V sterile topical gel developed to encourage the healing of equine wounds.
Vulketan contains ketanserin - a serotonin-S2 antagonist.2 Elanco says that although serotonin is more widely known as a neurotransmitter…
Elanco has announced that it has finalised its acquisition of Novartis Animal Health.
The acquisition, announced in April last year, follows Elanco's purchase of Lohmann Animal Health earlier in 2014. It swells Elanco's portfolio to nearly 300 brands…
Elanco Animal Health has announced a revision to the canine Atopica SPC, designed to provide veterinary surgeons with more flexible treatment options for canine atopic dermatitis
The updated license now states that consideration should be given to the…
Elanco Animal Health, maker of Comfortis, Trifexis and Atopica, has launched ScratchTracker, a smartphone app designed to help dog owners with a simple way to monitor pruritus in their pet and share the results with their vet.
Elanco says ScratchTracker…
Elanco Animal Health has launched an updated Atopica Comfort Club, a support initiative for veterinary professionals treating either canine atopic dermatitis or feline allergic dermatitis cases with Atopica.
The Atopica Comfort Club loyalty scheme now…
Elanco Animal Health has announced the launch of a Milbemax television advertising campaign to educate pet owners about the importance and ease of worming.
The 30-second advertisement will appear as pre-roll to video content on a number of websites from…